Back to Journals » Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy » Volume 13

Serum CA125 Level Is Associated with Diabetic Retinopathy in Chinese Patients with Type 2 Diabetes

Authors Yao L, Zhong Y, He L, Wang Y, Wu J, Geng J, Zhou Y, Zhang J, Chen J, Shan Z, Teng W, Xu Y, Chen L, Liu L

Received 23 February 2020

Accepted for publication 7 May 2020

Published 22 May 2020 Volume 2020:13 Pages 1803—1812

DOI https://doi.org/10.2147/DMSO.S250928

Checked for plagiarism Yes

Review by Single anonymous peer review

Peer reviewer comments 3

Editor who approved publication: Dr Konstantinos Tziomalos


Litong Yao,1,2,* Yifan Zhong,3,* Lingzi He,1,* Yan Wang,4,* Jingyang Wu,3 Jin Geng,3 Yun Zhou,3 Jiahua Zhang,3 Jun Chen,3 Zhongyan Shan,5 Weiping Teng,5 Yingying Xu,2 Lei Chen,3 Lei Liu3

1China Medical University, Shenyang 110001, People’s Republic of China; 2Department of Breast Surgery, The First Hospital of China Medical University, Shenyang 110001, People’s Republic of China; 3Department of Ophthalmology, The First Hospital of China Medical University, Shenyang 110001, People’s Republic of China; 4Department of Radiology, General Hospital of Liaohe Oil Field, Panjin 124010, People’s Republic of China; 5Department of Endocrinology and Metabolism, Institute of Endocrinology, Liaoning Provincial Key Laboratory of Endocrine Diseases, The First Affiliated Hospital of China Medical University, Shenyang 110001, People’s Republic of China

*These authors contributed equally to this work

Correspondence: Lei Chen; Lei Liu Email leichen51@hotmail.com; liuleijiao@163.com

Background: To investigate the association between serum carbohydrate antigen 125 (CA125) and the presence as well as severity of diabetes retinopathy (DR) in Chinese adult patients with type 2 diabetes.
Methods: A hospital-based cross-sectional study was conducted from February 2012 to November 2018. DR was assessed using Early Treatment Diabetic Retinopathy Study criteria. Vision-threatening DR (VTDR) was diagnosed if subjects had severe non-proliferative DR (NPDR), proliferative DR (PDR), or clinically significant macular edema (CSME). Multivariate logistic regression models were applied to explore the associations.
Results: Among the 2696 participants, the overall prevalence of DR was 25.1%, of which the prevalence of mild NPDR, moderate NPDR, and VTDR was 10.8%, 4.5%, and 9.9%, respectively. Serum CA125 level was significantly higher in participants with DR and increased with the severity of DR (P = 0.013). After accounting for age, gender, smoking, drinking, duration of diabetes, anti-diabetic agents use, systolic blood pressure, pulse pressure, weight, hemoglobin A1c and fasting plasma glucose levels, CA125 level was significantly associated with subjects in any-severity DR (odds ratio [OR] 1.006 [95% confidence interval CI: 1.002– 1.010], P = 0.006) and VTDR (1.008 [1.003– 1.013], P = 0.001). When CA125 was treated as categorized variables, the prevalence of VTDR might increase as improving CA125 quartiles (P value for trend = 0.017).
Conclusion: In this study, serum CA125 level was associated with the presence and severity of DR in Chinese patients with type 2 diabetes. Further prospective studies should be warranted to validate the feasible role of CA125 as well as other biomarkers.

Keywords: type 2 diabetes, diabetes retinopathy, tumor biomarker, CA125, association

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]